- $36.04m
- -$41.06m
- 21
- 47
- 10
- 14
REG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG - BlackRock Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - BlackRock Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG - LMR Partners LLP Mural Oncology PLC - Form 8.3 - Mural Oncology Plc
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
AnnouncementREG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc
AnnouncementREG-The Vanguard Group, Inc. Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
AnnouncementREG-Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Mural Oncology plc
Announcement